Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous valve replacement: a paradigm shift.

Anjan K Sinha1, Annapoorna S Kini, Samin K Sharma

  • 1Krannert Institute of Cardiology, Indianapolis, USA. samin.Sharma@mountsinai.org

Current Opinion in Cardiology
|September 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart Failure Pharmacotherapy Across the TAVR Continuum.

Journal of cardiac failure·2026
Same author

Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study.

Atherosclerosis·2026
Same author

TAVR in a Small Surgical Bioprosthesis With a Kinked Aortic Graft Using an Intra-Annular Self-Expanding Valve.

JACC. Case reports·2026
Same author

Sex differences in reverse remodeling after transcatheter aortic valve replacement in low-flow aortic stenosis.

The Journal of invasive cardiology·2026
Same author

Intra-coronary imaging and transcriptomics of calcified nodules before and after intensive lipid-lowering therapy: a YELLOW III substudy.

European heart journal. Imaging methods and practice·2026
Same author

A Proposed Anatomical-Fluoroscopic Workflow to Identify the Optimal Split Line for Leaflet Modification in Redo-TAVR.

JACC. Cardiovascular interventions·2026
Same journal

Contemporary medical management of left ventricular assist device patients: integrating sex-specific perspectives.

Current opinion in cardiology·2026
Same journal

Viability testing for guiding revascularization in ischemic cardiomyopathy.

Current opinion in cardiology·2026
Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
See all related articles

Percutaneous valve replacement offers a promising alternative for high-risk surgical patients with valvular heart disease. While long-term outcomes are still under investigation, new devices show potential for improved treatment options.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Valvular heart disease poses significant health risks, with surgical interventions carrying high complication rates, especially in elderly patients with comorbidities.
  • Elderly patients represent a growing demographic with complex health profiles, often making them unsuitable for traditional surgical valve repair.
  • Current surgical treatments for valvular lesions have limitations, particularly for high-risk patient groups.

Purpose of the Study:

  • To review recent advancements in percutaneous valve therapeutics.
  • To explore novel approaches for treating valvular lesions in high-risk surgical populations.
  • To provide an overview of emerging percutaneous valve replacement technologies.

Main Methods:

Related Experiment Videos

  • Review of recent technical developments in valvular interventions.
  • Analysis of emerging percutaneous valve replacement devices.
  • Evaluation of feasibility trial data for new valve therapeutics.

    • Main Results:

    • Percutaneous valve replacement has seen significant technical development over the past decade.
    • New percutaneous valve replacements are emerging as potential treatments for valvular lesions.
    • Semilunar valve interventions have shown more promising results compared to atrioventricular valves.

    Conclusions:

    • Several percutaneous devices are undergoing evaluation, with many more in development.
    • Long-term efficacy and safety data for percutaneous valve therapies are still pending.
    • Percutaneous approaches represent a developing frontier in managing valvular heart disease, particularly for high-risk patients.